Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 May;6(3):584-93.
doi: 10.1161/CIRCHEARTFAILURE.112.000096.

Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research

Andreas P Kalogeropoulos  1 , Vasiliki V Georgiopoulou, Barry A Borlaug, Mihai Gheorghiade, Javed Butler
Affiliations
Review

Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research

Andreas P Kalogeropoulos et al. Circ Heart Fail. 2013 May.
No abstract available

Keywords: heart failure; outcomes; prognosis; pulmonary hypertension; treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Six-month survival among patients hospitalized with acute heart failure according to their post-treatment pulmonary hypertension profile. Reproduced with permission from Aronson et al., Circ Heart Fail. 2011;4:644–650.
Figure 2
Figure 2
Echocardiographic estimation of pulmonary vascular resistance using the tricuspid regurgitation jet velocity (TRV) and the corresponding time-velocity integral (TVI). In this patient, despite a gradient of 72mmHg through the tricuspid valve, the estimated pulmonary vascular resistance (PVR) would be PVR=TRV(m/s)/TVI(cm)×10+0.16=(4.23/137.1)×10+0.16=0.47 Wood Units, suggesting the absence of a significant reactive component.
See this image and copyright information in PMC

References

    1. Delgado JF, Conde E, Sanchez V, Lopez-Rios F, Gomez-Sanchez MA, Escribano P, Sotelo T, Gomez de la Camara A, Cortina J, de la Calzada CS. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure. European journal of heart failure. 2005;7:1011–1016. - PubMed
    1. Gomberg-Maitland M, Dufton C, Oudiz R, Benza R. Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective. J Am Coll Cardiol. 2011;57:1053–1061. - PubMed
    1. Abramson SV, Burke JF, Kelly JJ, Jr, Kitchen JG, 3rd, Dougherty MJ, Yih DF, McGeehin FC, 3rd, Shuck JW, Phiambolis TP. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med. 1992;116:888–895. - PubMed
    1. Shalaby A, Voigt A, El-Saed A, Saba S. Usefulness of pulmonary artery pressure by echocardiography to predict outcome in patients receiving cardiac resynchronization therapy heart failure. Am J Cardiol. 2008;101:238–241. - PubMed
    1. Kjaergaard J, Akkan D, Iversen KK, Kjoller E, Køber L, Torp-Pedersen C, Hassager C. Prognostic importance of pulmonary hypertension in patients with heart failure. Am J Cardiol. 2007;99:1146–1150. - PubMed

MeSH terms